2 results
Approved WMORecruiting
Cohort-Expansion Stage (Single-Agent and Combination Therapy Cohorts):Primary:• To evaluate the preliminary efficacy of XB002 when administered alone and in combination therapy by determining the ORR per RECIST 1.1 (or other applicable response…
Approved WMOPending
Primary objective: To measure AF burden at population level.Secondary objective: Associate the AF burden with risk profiles in the general population.